Maggioni, Aldo P.

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study

Pieske, B., Maggioni, A. P., Lam, C. S. P., Pieske-Kraigher, E., Filippatos, G., Butler, J., Ponikowski, P., Shah, S. J., Solomon, S. D., Scalise, A.-V., et al. (2017) · European Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 366

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

Maggioni, A. P., Anand, I., Gottlieb, S. O., Latini, R., Tognoni, G., & Cohn, J. N. (2002) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 356

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Ducharme, A., Swedberg, K., Pfeffer, M. A., Cohen-Solal, A., Granger, C. B., Maggioni, A. P., Michelson, E. L., McMurray, J. J. V., Olsson, L., Rouleau, J. L., et al. (2006) · American Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 352

Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)

Lip, G. Y. H., Laroche, C., Ioachim, P. M., Rasmussen, L. H., Vitali-Serdoz, L., Petrescu, L., Darabantiu, D., Crijns, H. J. G. M., Kirchhof, P., Vardas, P., et al. (2014) · European Heart Journal

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 237

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 231

Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial

Sarma, S., Mentz, R. J., Kwasny, M. J., Fought, A. J., Huffman, M., Subacius, H., Nodari, S., Konstam, M., Swedberg, K., Maggioni, A. P., et al. (2013) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 202

In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry

Targher, G., Dauriz, M., Laroche, C., Temporelli, P. L., Hassanein, M., Seferovic, P. M., Drozdz, J., Ferrari, R., Anker, S., Coats, A., et al. (2017) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 169

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

Reith, C., Preiss, D., Blackwell, L., Emberson, J., Spata, E., Davies, K., Halls, H., Harper, C., Holland, L., Wilson, K., et al. (2024) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 161

Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial

Bhatt, D. L., Eikelboom, J. W., Connolly, S. J., Steg, P. G., Anand, S. S., Verma, S., Branch, K. R. H., Probstfield, J., Bosch, J., Shestakovska, O., et al. (2020) · Circulation

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 158

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

Jackson, A. M., Jhund, P. S., Anand, I. S., Düngen, H.-D., Lam, C. S. P., Lefkowitz, M. P., Linssen, G., Lund, L. H., Maggioni, A. P., Pfeffer, M. A., et al. (2021) · European Heart Journal

Heart Failure Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 156

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G.-A., Kalarus, Z., Crijns, H. J. G. M., Oliveira, M. M., Tavazzi, L., et al. (2015) · Europace

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 151

Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA heart failure long-term registry

Dauriz, M., Targher, G., Laroche, C., Temporelli, P. L., Ferrari, R., Anker, S., Coats, A., Filippatos, G., Crespo-Leiro, M., Mebazaa, A., et al. (2017) · Diabetes Care

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 139

Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL trial

Bethel, M. A., Mentz, R. J., Merrill, P., Buse, J. B., Chan, J. C., Goodman, S. G., Iqbal, N., Jakuboniene, N., Katona, B., Lokhnygina, Y., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 112

Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries

Smyth, A., Dehghan, M., O'Donnell, M., Anderson, C., Teo, K., Gao, P., Sleight, P., Dagenais, G., Probstfield, J. L., Mente, A., et al. (2015) · Neurology

Nutritional Studies and DietDementia and Cognitive Impairment Research

Cited by 85

Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V

Ferrannini, G., De Bacquer, D., De Backer, G., Kotseva, K., Mellbin, L., Wood, D., Rydén, L., collaborators, E. V., Gale, C. P., Beleslin, B., et al. (2020) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 75

Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia

Gerstein, H. C., Paré, G., McQueen, M. J., Haenel, H., Lee, S. F., Pogue, J., Maggioni, A. P., Yusuf, S., & Hess, S. (2015) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 69

Confirming the bidirectional nature of the association between severe hypoglycemic and cardiovascular events in type 2 diabetes: insights from EXSCEL

Standl, E., Stevens, S. R., Lokhnygina, Y., Bethel, M. A., Buse, J. B., Gustavson, S. M., Maggioni, A. P., Mentz, R. J., Hernandez, A. F., & Holman, R. R. (2020) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 65

Relationship Between Clinical Trial Site Enrollment With Participant Characteristics, Protocol Completion, and Outcomes

Butler, J., Subacius, H., Vaduganathan, M., Fonarow, G. C., Ambrosy, A. P., Konstam, M. A., Maggioni, A., Mentz, R. J., Swedberg, K., Zannad, F., et al. (2013) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 60

Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation

Proietti, M., Raparelli, V., Laroche, C., Dan, G.-A., Janion, M., Popescu, R., Sinagra, G., Vijgen, J., Boriani, G., Maggioni, A. P., et al. (2017) · EP Europace

Atrial Fibrillation Management and OutcomesPeripheral Artery Disease Management

Cited by 58

Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF

Feinstein, M. J., Jhund, P., Kang, J., Ning, H., Maggioni, A., Wikstrand, J., Kjekshus, J., Tavazzi, L., McMurray, J., & Lloyd-Jones, D. M. (2015) · European Journal of Heart Failure

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 56

Survival and hospitalization in heart failure patients with or without diabetes treated with β-blockers

Bobbio, M., Ferrua, S., Opasich, C., Porcu, M., Lucci, D., Scherillo, M., Tavazzi, L., & Maggioni, A. P. (2003) · Journal of Cardiac Failure

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 56

Depression Worsens Outcomes in Elderly Patients with Heart Failure: An Analysis of 48,117 Patients in a Community Setting

Macchia, A., Monte, S., Pellegrini, F., Romero, M., D'Ettorre, A., Tavazzi, L., Tognoni, G., & Maggioni, A. P. (2008) · European Journal of Heart Failure

Cardiac Health and Mental HealthHeart Failure Treatment and Management

Cited by 55

The ‘real’ woman with heart failure: impact of sex on current in-hospital management of heart failure by cardiologists and internists.

Opasich, C., De Feo, S., Ambrosio, G. A., Bellis, P., Di Lenarda, A., Di Tano, G., Fico, D., Gonzini, L., Lavecchia, R., Tomasi, C., et al. (2004) · European Journal of Heart Failure

Heart Failure Treatment and ManagementSex and Gender in Healthcare

Cited by 44

Pregnancy outcomes in women with aortic coarctation

Ramlakhan, K. P., Tobler, D., Greutmann, M., Schwerzmann, M., Baris, L., Yetman, A. T., Nihoyannopoulos, P., Manga, P., Boersma, E., Maggioni, A. P., et al. (2021) · Heart

Cardiovascular Issues in PregnancyCongenital Heart Disease Studies

Cited by 42